Literature DB >> 963894

An active site peptide from human placental alkaline phosphatase.

K B Whitaker, P G Byfield, D W Moss.   

Abstract

A preparation of human placental alkaline phosphatase was labelled covalently at the active site with [32P]orthophosphate. Treatment with trypsin gave essentially one radioactive peptide, the active site peptide, of approximately 2300 molecular weight. Dansylation of the peptide showed that the amino-terminal residue was glycine. After acid hydrolysis the only radioactively-labelled amino acid present was serine phosphate. The amino acid composition was similar to those compositions reported for active site peptides from other alkaline phosphatases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963894     DOI: 10.1016/0009-8981(76)90542-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  The scientific foundations of clinical enzymology.

Authors:  D W Moss
Journal:  Naturwissenschaften       Date:  1977-05

2.  Comparison of radioactive peptides obtained from specifically labelled human renal and placental alkaline phosphatases.

Authors:  K B Whitaker; D W Moss
Journal:  Biochem J       Date:  1979-10-01       Impact factor: 3.857

3.  Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA.

Authors:  W Kam; E Clauser; Y S Kim; Y W Kan; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.